Business · 31/07/1997
FDA to Hold Public Hearing on Pregnancy Labeling for Human Prescription Drugs
The FDA is seeking public input on the content and format of labeling for human prescription drugs, specifically the pregnancy subsection, to address concerns that the current categories may be misleading and confusing for clinicians and patients.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →